Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tracy E. Wiczer"'
Autor:
Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Rogers, Anli McCoy, Luay Mousa, Avirup Guha, Nyla A. Heerema, Kami Maddocks, Beth Christian, Leslie A. Andritsos, Samantha Jaglowski, Steven Devine, Robert Baiocchi, Jennifer Woyach, Jeffrey Jones, Michael Grever, Kristie A. Blum, John C. Byrd, Farrukh T. Awan
Publikováno v:
Blood Advances, Vol 1, Iss 20, Pp 1739-1748 (2017)
Abstract: Atrial fibrillation (AF) has been reported in up to 16% of patients taking ibrutinib. Data regarding the management of AF in this patient population are limited, and stroke prevention poses a challenge because of increased risk of bleeding
Externí odkaz:
https://doaj.org/article/54d5dabd52f24cfa86524782f1940ea1
Autor:
Seema A. Bhat, John Gambril, Leylah Azali, Sunnia T. Chen, Lindsay Rosen, Marilly Palettas, Tracy E. Wiczer, Sujay Kalathoor, Qiuhong Zhao, Kerry A. Rogers, Adam Kittai, Michael Grever, Farrukh Awan, Patrick Ruz, John C. Byrd, Jennifer Woyach, Daniel Addison
Publikováno v:
Blood. 140:2142-2145
Acalabrutinib, a next-generation Bruton’s tyrosine kinase inhibitor (BTKi), associates with dramatic efficacy against B-cell malignancies. Recently, unexplained ventricular arrhythmias (VAs) with next-generation BTKi-therapy have been reported. Yet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6779753bae180c9e0dafa99a9e8bf3fd
https://doi.org/10.1182/blood.2022016953
https://doi.org/10.1182/blood.2022016953